![Paul Brooke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Brooke
Président chez
Caelum Biosciences, Inc.
Profil
Paul Alan Brooke is the founder of Ithaka Acquisition Corp.
(founded in 2005) and venBio Partners LLC (founded in 2009).
He is currently the Chairman of Caelum Biosciences, Inc. and a Director at Manning & Napier Fund, Inc., Cellenkos, Inc., and Blacksmith Institute, Inc. He is also the Managing Member of PMSV Holdings LLC since 1993.
In the past, he held positions such as Chairman & Chief Executive Officer at Alsius Corp.
(2005-2007), Chairman at ALUS Liquidation Corp.
(2009), and Independent Director at Incyte Corp.
(2001-2020).
He was also a Managing Director at Tiger Management LLC (1999-2000) and a Director at Emdeon Corp.
(2000-2007).
He has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Columbia College (New York).
Postes actifs de Paul Brooke
| Sociétés | Poste | Début |
|---|---|---|
PMSV Holdings LLC
 PMSV Holdings LLC Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | 01/01/1993 |
Manning & Napier Fund, Inc.
 Manning & Napier Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Directeur/Membre du Conseil | - |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Président | 01/07/2018 |
Cellenkos, Inc.
 Cellenkos, Inc. Pharmaceuticals: MajorHealth Technology Manufactures autoimmune diseases drugs | Directeur/Membre du Conseil | - |
Blacksmith Institute, Inc.
 Blacksmith Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that protects children and pregnant women | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Brooke
| Sociétés | Poste | Fin |
|---|---|---|
| INCYTE CORPORATION | Directeur/Membre du Conseil | 26/05/2020 |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Directeur/Membre du Conseil | 31/05/2014 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Directeur/Membre du Conseil | 01/01/2014 |
WebMD, Inc.
 WebMD, Inc. Internet Software/ServicesTechnology Services Provides Internet-based services and information for physicians and health care information services for consumers | Directeur/Membre du Conseil | 01/10/2010 |
| ░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Paul Brooke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Manning & Napier Fund, Inc.
Manning & Napier Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Tiger Management LLC
 Tiger Management LLC Investment ManagersFinance Tiger Management employs a passive, multi-strategy, fund-of-fund investment approach. The firm also provides seed capital to other upcoming hedge fund managers. | Finance |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Emdeon Corp.
 Emdeon Corp. Data Processing ServicesTechnology Services Develops Internet-based information and transaction processing of health care information systems | Technology Services |
GMP Cos., Inc.
 GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, diagnostic products, and medical devices | Health Technology |
MPM BioEquities Adviser LLC
 MPM BioEquities Adviser LLC Investment ManagersFinance MPM BioEquities Adviser focuses exclusively on global life sciences investments. The firm invests in biotechnology, specialty pharmaceuticals, medical technology and related companies that provide innovative medical products and services to the healthcare industry. They invest across all geographies, stages of development and therapeutic areas. MPM focuses on inflection points in the development of companies, such as the achievement of clinical proof-of-concept data and the achievement of early commercial success, and on reinvigorating commercial platforms with potentially high growth assets. MPM BioVentures I (BB BioVentures, MPM BioVentures Parallel Fund) is a family of funds that was launched in 1997 and is no fully committed with 75% of its investments in biotechnology and 25% in medical devices and other healthcare related fields. The MPM BioVentures I portfolio consists of 26 companies with investments ranging from $5 million to $20 million per company. Within the biotechnology sector, the funds' investments are split between companies focused on therapeutics and enabling technologies. About 80% of the funds' assets are invested in US companies and 20% in European companies. The MPM BioVentures II family of funds closed in the first quarter of 2000. The funds consist of investments in biotechnology, medical devices and other healthcare related fields. The MPM BioVentures II has invested in 35 companies, with investments ranging from $10 million to $50 million. The fund has invested across the entire spectrum of company development, from start-up through mezzanine and PIPES. 85% of the funds' investments are in US companies and 15% are in European and Asian companies. The MPM BioVentures III Fund closed in December of 2002. The fund holds a portfolio of 39 companies, 85% of which are focused on biotechnology and pharmaceutical products and 15% are focused on medical devices and life science tools. The fund's balanced portfolio of early-, mid- and late-stage companies includes investments in public companies through PIPE transactions. The MPM BioVentures IV family of funds was launched in the second quarter of 2006. The funds hold a portfolio of 18 companies with investments ranging from $5 million to $36 million. About 75% of the funds' investments focus on biotechnology and pharmaceutical products and 25% focus on medical device companies. About 25% of the funds' investments have been made outside the US, including investments in Asia and Europe. The MPM BioVentures IV family of funds serves as the lead investor in a majority of its investments and takes an active role as a board member on its portfolio companies' boards of directors. | Finance |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Ithaka Acquisition Corp.
 Ithaka Acquisition Corp. Financial ConglomeratesFinance Development stage company | Finance |
WebMD Health Corp.
 WebMD Health Corp. Internet Software/ServicesTechnology Services Provides digital health information, medical education, clinical assessment and patient education services | Technology Services |
HoustonPharma, Inc.
 HoustonPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and technologies | Health Technology |
LifeSync Holdings, Inc.
 LifeSync Holdings, Inc. Medical SpecialtiesHealth Technology Operates as a holding company with interest in medical devices | Health Technology |
Manning & Napier, Inc.
 Manning & Napier, Inc. Investment ManagersFinance Operates as a wealth advisory firm | Finance |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
WebMD, Inc.
WebMD, Inc. Internet Software/ServicesTechnology Services Provides Internet-based services and information for physicians and health care information services for consumers | Technology Services |
Morgan Stanley Japan Ltd.
 Morgan Stanley Japan Ltd. Investment Banks/BrokersFinance Provides investment banking and institutional securities services | Finance |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Alsius Corp. /Old/
 Alsius Corp. /Old/ Medical DistributorsDistribution Services Provides health care products | Distribution Services |
PMSV Holdings LLC
PMSV Holdings LLC Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Cheyne Capital LLC
 Cheyne Capital LLC Investment ManagersFinance Cheyne Capital specializes in investment opportunities in the following areas: corporate credit, real estate and asset-backed strategies, event-driven, convertible bonds, equity strategies and fund-of-funds. The firm seeks to generate above-average, risk-adjusted absolute rates of return for their clients. Their investment methodology combines fundamental analysis with a proactive trading approach to trading | Finance |
HLTH Corp.
 HLTH Corp. Internet Software/ServicesTechnology Services Develops Internet-based information and transaction processing of health care information systems | Technology Services |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
ALUS Liquidation Corp.
 ALUS Liquidation Corp. Medical SpecialtiesHealth Technology Develops, manufactures and sells medical products | Health Technology |
Avoro Capital Advisor LLC
 Avoro Capital Advisor LLC Investment ManagersFinance AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies. | Finance |
Columbia College (New York)
 Columbia College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Cellenkos, Inc.
Cellenkos, Inc. Pharmaceuticals: MajorHealth Technology Manufactures autoimmune diseases drugs | Health Technology |
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Blacksmith Institute, Inc.
Blacksmith Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that protects children and pregnant women | Commercial Services |
